{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T17:29:15Z","timestamp":1659115755589},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T00:00:00Z","timestamp":1409097600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s12328-014-0527-x","type":"journal-article","created":{"date-parts":[[2014,8,26]],"date-time":"2014-08-26T08:59:38Z","timestamp":1409043578000},"page":"465-470","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Severe liver injury associated with simeprevir plus pegylated interferon\/ribavirin therapy in a patient with treatment-na\u00efve genotype 1b hepatitis C virus: a case report"],"prefix":"10.1007","volume":"7","author":[{"given":"Takuro","family":"Igawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fusao","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Nouso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harushige","family":"Nakatsukasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,27]]},"reference":[{"key":"527_CR1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00535-005-1740-7","volume":"41","author":"N Hayashi","year":"2006","unstructured":"Hayashi N, Takehara T. Antiviral therapy for chronic hepatitis C: past, present, and future. J Gastroenterol. 2006;41:17\u201327.","journal-title":"J Gastroenterol"},{"key":"527_CR2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/liv.12300","volume":"34","author":"MP Manns","year":"2014","unstructured":"Manns MP, McCone J, Davis MN, et al. Overall safety profile of boceprevir plus peginterferon alfa-2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2\/3 clinical trials. Liver Intern. 2014;34:707\u201319.","journal-title":"Liver Intern"},{"key":"527_CR3","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1056\/NEJMoa1012912","volume":"364","author":"IM Jacobson","year":"2011","unstructured":"Jacobson IM, McHutchison JG, Dusheiko G, et al. Telaprevir for previously untreated chronic hepatitis C virus infection. N Eng J Med. 2011;364:2405\u201316.","journal-title":"N Eng J Med"},{"key":"527_CR4","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/apt.12764","volume":"39","author":"MH Miller","year":"2014","unstructured":"Miller MH, Agarwal K, Austin A, et al. Review article: 2014 UK consensus guidelines\u2014hepatitis C management and direct-acting anti-viral therapy. Alimentary Pharmacology Ther. 2014;39:1363\u201375.","journal-title":"Alimentary Pharmacology Ther"},{"key":"527_CR5","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/hep.26641","volume":"58","author":"MW Fried","year":"2013","unstructured":"Fried MW, Buti M, Dore GJ, et al. Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-na\u00efve genotype 1 hepatitis C: the randomized PILLAR study. Hepatology. 2013;58:1918\u201329.","journal-title":"Hepatology"},{"key":"527_CR6","doi-asserted-by":"crossref","unstructured":"Hayashi N, Izumi N, Kumada H, et al. Simeprevir with peginterferon\/ribavirin for treatment-na\u00efve hepatitis C genotype 1 patients in Japan: CONCERTO-1, a phase III trial. J Hepatol. 2014;61(2):219\u201327.","DOI":"10.1016\/j.jhep.2014.04.004"},{"key":"527_CR7","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00535-014-0949-8","volume":"49","author":"N Izumi","year":"2014","unstructured":"Izumi N, Hayashi N, Kumada H, et al. Once-daily simeprevir with peginterferon and ribavirin for treatment-experienced HCV genotype 1-infected patients in Japan: the CONCERTO-2 and CONCERTO-3 studies. J Gastroenterol. 2014;49:941\u201353.","journal-title":"J Gastroenterol"},{"key":"527_CR8","unstructured":"Report of SOVRIAD early post-marketing phase surveillance in Japan, in preparation."},{"key":"527_CR9","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/j.1365-2036.2007.03322.x","volume":"25","author":"PH Thurairajah","year":"2007","unstructured":"Thurairajah PH, Thorburn D, Hubscher S, et al. Incidence and characterization of serum transaminases elevations in pegylated interferon and ribavirin treated patients with chronic hepatitis C. Aliment Pharmacol Ther. 2007;25:1293\u2013300.","journal-title":"Aliment Pharmacol Ther"},{"key":"527_CR10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s15010-003-3129-y","volume":"31","author":"G Just-N\u00fcbling","year":"2003","unstructured":"Just-N\u00fcbling G, Korn S, Ludwig B, et al. Primary cytomegalovirus infection in an outpatient setting\u2013laboratory markers and clinical aspects. Infection. 2003;31:318\u201323.","journal-title":"Infection"},{"key":"527_CR11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2957\/kanzo.46.85","volume":"46","author":"H Takikawa","year":"2005","unstructured":"Takikawa H, Onji M, Takamori Y, et al. Proposal of diagnostic criteria for drug-induced liver injury revised by the DDW-J 2004 Workshop. Kanzo. 2005;46:85\u201390 (in Japanese).","journal-title":"Kanzo"},{"key":"527_CR12","volume-title":"Scheuer\u2019s liver biopsy interpretation","author":"H Jay Lefkowitch","year":"2010","unstructured":"Jay Lefkowitch H. Scheuer\u2019s liver biopsy interpretation. 8th ed. Edinburgh: Elsevier Saunders; 2010.","edition":"8"},{"key":"527_CR13","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1053\/j.gastro.2013.12.032","volume":"146","author":"RJ Fontana","year":"2014","unstructured":"Fontana RJ. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives. Gastroenterology. 2014;146:914\u201328.","journal-title":"Gastroenterology"},{"issue":"1","key":"527_CR14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0168-8278(96)80184-X","volume":"24","author":"G Fattovich","year":"1996","unstructured":"Fattovich G, Giustina G, Favarato S, et al. A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol. 1996;24(1):38\u201347.","journal-title":"J Hepatol"},{"issue":"5","key":"527_CR15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1155\/2001\/510742","volume":"15","author":"I Kraus","year":"2001","unstructured":"Kraus I, Vitezic D. Acute hepatitis induced by alpha-interferon in a patient with chronic hepatitis C. Can J Gastroenterol. 2001;15(5):333\u20135.","journal-title":"Can J Gastroenterol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-014-0527-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12328-014-0527-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-014-0527-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T18:24:56Z","timestamp":1598207096000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12328-014-0527-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,27]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["527"],"URL":"https:\/\/doi.org\/10.1007\/s12328-014-0527-x","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,27]]}}}